Z P Nagy
Overview
Explore the profile of Z P Nagy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
531
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hipp H, Gaskins A, Nagy Z, Capelouto S, Shapiro D, Spencer J
Hum Reprod
. 2020 Mar;
35(4):847-858.
PMID: 32142582
Study Question: How does ovarian stimulation in an oocyte donor affect the IVF cycle and obstetric outcomes in recipients? Summary Answer: Higher donor oocyte yields may affect the proportion of...
2.
Nel-Themaat L, Nagy Z
Placenta
. 2011 Jun;
32 Suppl 3:S257-63.
PMID: 21703683
Embryo viability assessment is one of the most important and challenging tasks in IVF. Evaluation of embryo quality is critical when selecting the best embryo(s) to transfer or cryopreserve. Until...
3.
Vajta G, Nagy Z, Cobo A, Conceicao J, Yovich J
Reprod Biomed Online
. 2009 Dec;
19 Suppl 3:1-7.
PMID: 20034418
The purpose of this work is to update embryologists and clinicians on different approaches in human oocyte and embryo cryopreservation, by clarifying some misunderstandings and explaining the underlying reasons for...
4.
Greco E, Litwicka K, Ferrero S, Sapienza F, Minasi M, Iacobelli M, et al.
Reprod Biomed Online
. 2008 Oct;
17(4):530-6.
PMID: 18854108
Italian legislation regarding reproductive medicine prohibits embryo storage while allowing cryopreservation of supernumerary oocytes. This study evaluated the effect of fresh oocytes obtained from natural unstimulated cycles on the clinical...
5.
Bourdette D, Edmonds E, Smith C, Bowen J, Guttmann C, Nagy Z, et al.
Mult Scler
. 2005 Oct;
11(5):552-61.
PMID: 16193893
Background: T cell receptor (TCR) peptide vaccination is a novel approach to treating multiple sclerosis (MS). The low immunogenicity of previous vaccines has hindered the development of TCR peptide vaccination...
6.
Tesarik J, Nagy Z, Sousa M, Mendoza C, Abdelmassih R
Reprod Biomed Online
. 2003 Jan;
2(3):160-164.
PMID: 12537791
The only assisted reproduction treatment now available for women with ovarian failure or irreparable oocyte defects is oocyte donation. However, some women experience psychological barriers to the recourse to donor...
7.
Abdelmassih S, Cardoso J, Abdelmassih V, Dias J, Abdelmassih R, Nagy Z
Hum Reprod
. 2002 Sep;
17(10):2694-9.
PMID: 12351550
Background: Degeneration of oocytes occurs even when maximum care is exercised during ICSI, especially when the oolemma is very fragile and/or the zona pellucida is resistant. In order to be...
8.
da Costa AL A, Abdelmassih S, de Oliveira F, Abdelmassih V, Abdelmassih R, Nagy Z, et al.
Hum Reprod
. 2001 Feb;
16(2):333-6.
PMID: 11157829
The incidence of monozygotic twinning (MZT) is higher in pregnancies conceived after assisted reproduction than after natural conception. Alterations, produced by ovarian stimulation, in-vitro culture conditions and specifically alterations of...
9.
Nagy Z
Mol Cell Endocrinol
. 2000 Sep;
166(1):59-62.
PMID: 10989209
The two main causes of complete or nearly complete asthenozoospermia are necrozoospermia (presence of only non-viable spermatozoa) and the different ultrastructural abnormalities of spermatozoa. Ultrastructural alterations may affect also the...
10.
Tesarik J, Nagy Z, Mendoza C, Greco E
Hum Reprod
. 2000 Apr;
15(5):1149-54.
PMID: 10783368
Most current studies of nuclear transfer in mammalian oocytes have used electrofusion to incorporate donor cell nuclei into enucleated oocyte cytoplasts. However, the application of electrofusion to human oocytes is...